Evidence map›Paper›PMID 39041203›Full record

ArticleCardiovascular research2024

Cross-species single-cell RNA sequencing reveals divergent phenotypes and activation states of adaptive immunity in human carotid and experimental murine atherosclerosis.

Hauke Horstmann, Nathaly Anto Michel, Xia Sheng, Sophie Hansen, Alexandra Lindau, Katharina Pfeil, Marbely C Fernández, Timoteo Marchini, Holger Winkels, Lucia Sol Mitre and 24 more

Abstract readComparative Study
In one paragraph

Article in Cardiovascular research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Hauke HorstmannDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Nathaly Anto MichelDepartment of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria.
Xia ShengDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Sophie HansenDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Alexandra LindauDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Katharina PfeilDivision of Cardiology, Department of Medicine, NYU Cardiovascular Research Center, NYU Grossmann School of Medicine, 10016 New York, NY, USA.
Marbely C FernándezFaculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Timoteo MarchiniDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Holger WinkelsDepartment of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50923 Cologne, Germany.ORCID 0000-0003-1333-2031
Lucia Sol MitreDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Tijani AbogunlokoDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Xiaowei LiDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Timothy Bon-Nawul MwinyellaDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Mark Colin GisslerDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Heiko BuggerFaculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Timo HeidtDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Konrad BuscherDivision of General Internal Medicine, Nephrology and Rheumatology, Department of Medicine, University Hospital of Münster, 48149 Münster, Germany.
Ingo HilgendorfDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.ORCID 0000-0002-0024-1643
Peter StachonDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Sven PiepenburgDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Nicolas VerheyenDepartment of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0001-7414-4056
Thomas RathnerDepartment of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria.
Teresa GerhardtDepartment of Cardiology, Angiology and Intensive Care Medicine CBF, Deutsches Herzzentrum der Charité, and Berlin Institute of Health (BIH), 13353 Berlin, Germany.ORCID 0000-0002-6144-5279
Patrick Malcolm SiegelDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Wolfgang Kurt OswaldDepartment of Vascular Surgery, Medical University of Graz, 8036 Graz, Austria.
Tina CohnertDepartment of Vascular Surgery, Medical University of Graz, 8036 Graz, Austria.
Alma ZerneckeInstitute of Experimental Biomedicine, University Hospital Würzburg, 97080 Würzburg, Germany.
Josef MadlFaculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Peter KohlFaculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Amanda C FoksLeiden Academic Centre for Drug Research, Division of BioTherapeutics, Leiden University, 2333 CC Leiden, The Netherlands.
Constantin von Zur MuehlenDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.
Dirk WestermannDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.ORCID 0000-0002-7542-1956
Andreas ZirlikDepartment of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria.ORCID 0000-0001-6290-3297
Dennis WolfDepartment of Cardiology and Angiology I, Medical Center, University of Freiburg, 79106 Freiburg, Germany.

Funding

European Research Council 853425German Research Foundation #422681845University of Freiburg
6 · The paper itself

Abstract

aimsThe distinct functions of immune cells in atherosclerosis have been mostly defined by pre-clinical mouse studies. Contrastingly, the immune cell composition of human atherosclerotic plaques and their contribution to disease progression are only poorly understood. It remains uncertain whether genetic animal models allow for valuable translational approaches. METHODS AND

resultsSingle-cell RNA-sequencing (scRNA-seq) was performed to define the immune cell landscape in human carotid atherosclerotic plaques. The human immune cell repertoire demonstrated an unexpectedly high heterogeneity and was dominated by cells of the T-cell lineage, a finding confirmed by immunohistochemistry. Bioinformatical integration with 7 mouse scRNA-seq data sets from adventitial and atherosclerotic vascular tissue revealed a total of 51 identities of cell types and differentiation states, of which some were only poorly conserved between species and exclusively found in humans. Locations, frequencies, and transcriptional programmes of immune cells in mouse models did not resemble the immune cell landscape in human carotid atherosclerosis. In contrast to standard mouse models of atherosclerosis, human plaque leucocytes were dominated by several T-cell phenotypes with transcriptional hallmarks of T-cell activation and memory formation, T-cell receptor, and pro-inflammatory signalling. Only mice at the age of 22 months partially resembled the activated T-cell phenotype. In a validation cohort of 43 patients undergoing carotid endarterectomy, the abundance of activated immune cell subsets in the plaque defined by multi-colour flow cytometry associated with the extent of clinical atherosclerosis.

conclusionIntegrative scRNA-seq reveals a substantial difference in the immune cell composition of murine and human carotid atherosclerosis-a finding that questions the translational value of standard mouse models for adaptive immune cell studies. Clinical associations suggest a specific role for T-cell driven (auto-)immunity in human plaque formation and instability.

Indexed as

Adaptive ImmunityCarotid Artery DiseasesDisease Models, AnimalMice, Inbred C57BLPhenotypePlaque, AtheroscleroticRNA-SeqSingle-Cell AnalysisSpecies SpecificityAgedAnimalsCarotid ArteriesFemaleHumansLymphocyte ActivationMaleAtherosclerosisImmunityLeucocytesPredictionScRNA-seqTranscriptome

Identifiers

PMID39041203
PMCPMC11587564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.